Clinical trial
Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia: Prognosis and Impact on the Respiratory and Cardiovascular Systems.
NCT05197686 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia: Prognosis and Impact on the Respiratory and Cardiovascular Systems.
- Lead sponsor
- Pomeranian Medical University Szczecin
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 18, 2022
- Completion date
- December 31, 2022
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ards due to disease caused by severe acute respiratory syndrome coronavirus 2, corona virus infection, oxygen deficiency